TB researchers Zhou Xing and Amy Gillgrass explain why they are optimistic about a future with better TB outcomes.
It can design new antibiotics to stop the spread of Acinetobacter baumannii, which the World Health Organization has identified as one of the world’s most dangerous antibiotic-resistant bacteria.
Led by CEO John Valliant, the company that develops next-generation precision cancer medicines will become a wholly owned subsidiary of AstraZeneca and continue its operations at its state-of-the-art facility at McMaster Innovation Park.
McMaster logo
McMaster logo
